Cycle Pharmaceuticals (Cycle) has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of ...

Also known as PAH deficiency, phenylketonuria is a genetic condition. Credit: bangoland / Shutterstock. BioMarin Pharmaceutical has reported that the multi-centre Phase III PEGASUS trial of Palynziq ...

PEGASUS is a Phase 3 multi-center open-label randomized controlled study evaluating the safety and efficacy of PALYNZIQ compared to diet alone in 55 adolescents aged 12-17 with phenylketonuria.